Richard Rowley Buys Shares of OBT
Richard Rowley purchased 132 shares of OBT for $4,666.20.
Key Points
- Richard Rowley purchased 132 shares of OBT at $35.35 each, totaling $4,666.20.
- OBT shares recently traded at $36.04, with notable insider buying activity on June 15, 2026.
- Piper Sandler maintains a 'buy' rating on OBT, with a recent price target of $36.00.
On June 15, 2026, Richard Rowley purchased 132 shares of OBT at an average price of $35.35 per share, totaling $4,666.20. This transaction was not part of a pre-arranged trading plan.
Insider Buying and Selling at OBT
Several insiders made purchases of OBT shares on June 15, 2026. Gregory Sousa, EVP and Deputy CLO, bought 25 shares at $35.35 each. William Morrison acquired 11 shares, and Jonathan Rouis bought 37 shares, both at the same price. Richard Rowley added 132 shares, while Kevin Keane purchased 92 shares. Michael Lesler, EVP and CFO, also bought 13 shares.
Other Institutional Activity in OBT
Among OBT's institutional investors, BlackRock, Inc. decreased its holdings by 50,029 shares, now holding 1,892,320 shares worth about $60.5 million. Orange Investment Advisors, Inc. reduced its position by 40,127 shares, ending with 1,061,490 shares valued at approximately $33.9 million. Wellington Management Group LLP trimmed its stake by 76,848 shares, leaving it with 497,422 shares worth $15.9 million. In contrast, Vanguard Capital Management LLC significantly increased its position, adding 461,702 shares to hold a total of 461,702 shares, valued at around $14.8 million.
Analysts Set New Price Targets
Piper Sandler maintained its 'buy' rating on OBT on February 5, 2026, setting a price target of $36.00. The firm has consistently upheld its positive outlook on the stock with various price targets over the past years.
Bottom Line
Richard Rowley's purchase of 132 OBT shares reflects ongoing insider interest in the company. OBT's stock, recently trading at $36.04, is closely watched by analysts and investors alike. Piper Sandler's maintained 'buy' rating and $36.00 price target suggest continued optimism about the company's prospects.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
